Down Nearly 20%: Should You Buy the Dip on Eli Lilly?
Several factors have contributed to Lilly's share price decline, including earnings misses and increased competition.
However, Lilly's growth prospects still look promising.
10 stocks we like better than Eli Lilly ›
For a while, it seemed as if Eli Lilly (NYSE: LLY) could do no wrong. Its shares skyrocketed. The company's market cap grew so much that it was within striking distance of the $1 trillion mark. Along the way, Lilly became the largest healthcare company in the world based on market cap.
However, the situation isn't so rosy for Eli Lilly now. The big pharma stock has fallen nearly 20% below its peak set last year. Some dark clouds hover on the horizon. Should you buy Lilly on the dip?
There isn't just one factor behind the decline in Lilly's share price. However, the biggest issue for the drugmaker is a common one for high-flying stocks: Lilly didn't meet Wall Street estimates. Unfortunately, the company has failed to deliver the results analysts expected in two out of the last three quarters.
The worst miss was in the third quarter of 2024, when Lilly's earnings came in roughly 19.5% below the consensus estimate. More recently, the big pharma company narrowly missed earnings expectations by around 3.4%. Regardless of the size of the miss, though, investors expect a stock with a forward price-to-earnings ratio of 36.6 to be practically perfect.
Concerns about rising competition in the obesity drug market have also weighed on Lilly's share price. Novo Nordisk is on track to file for regulatory approval of CagriSema in early 2026. CVS Health recently chose Novo Nordisk's weight-loss drug Wegovy as a preferred drug on its formulary over Zepbound. Roche teamed up with Zealand Pharma, which has a promising weight-loss drug in clinical development. Viking Therapeutics is advancing its experimental obesity drug VK2735 into late-stage clinical testing.
To add more uncertainty to the mix, the Trump administration has threatened major tariffs on pharmaceutical imports. Lilly CEO David Ricks acknowledged in the company's Q1 earnings call that tariffs "would have a negative effect on Lilly and for our industry."
Reuters also recently reported that the White House is considering implementing international reference pricing, which would peg the price Medicare pays for prescription drugs to the prices that other major countries pay. Ricks said in the Q1 call that looking at U.S. versus European list prices for drugs in isolation is "a nonsensical idea."
Why consider buying Lilly stock with these issues in the forefront? The most important reason to invest in the drugmaker is still its growth prospects.
Sales are booming for Lilly's tirzepatide products, Mounjaro and Zepbound. The company's market share for incretin analogs now tops 50%. Notably, Lilly's market share is increasing while Novo Nordisk's share is decreasing.
Lilly's pipeline features other promising obesity drugs as well. The company plans to file for approvals of orforglipron (a weight-loss pill taken daily) later this year, pending successful completion of current phase 3 studies. Lilly hopes to follow up with regulatory submissions of orforglipron as a treatment for type 2 diabetes in the first half of 2026.
Breast cancer drug Verzenio continues to enjoy solid momentum, with sales jumping 10% year over year in Q1. The therapy is especially growing in international markets.
Lilly has 25 programs in late-stage testing, notably including Jaypirca as a first-line monotherapy for chronic lymphocytic leukemia and olomorasib in treating non-small cell lung cancer. The company also awaits regulatory approvals for tirzepatide in heart failure with preserved ejection fraction and imlunestrant in breast cancer.
Should investors buy Lilly stock on the dip? I think it's important to weigh all the pros and cons first. However, the balance tips in favor of investing in this drugmaker, in my opinion.
I fully expect Lilly to remain a dominant player in the obesity and type 2 diabetes markets. The company should continue to make inroads in oncology and other indications. The Trump administration's potential pharmaceutical tariffs and Medicare pricing changes are wild cards that could change the dynamics. Still, though, I think Lilly's sell-off presents a buying opportunity.
Before you buy stock in Eli Lilly, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Eli Lilly wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $613,546!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $695,897!*
Now, it's worth noting Stock Advisor's total average return is 893% — a market-crushing outperformance compared to 162% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of May 5, 2025
Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends CVS Health, Novo Nordisk, Roche Holding AG, and Viking Therapeutics. The Motley Fool has a disclosure policy.
Down Nearly 20%: Should You Buy the Dip on Eli Lilly? was originally published by The Motley Fool
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
16 minutes ago
- Axios
Scoop: DNC rents taco truck to mock Trump on 'TACO' slogan
The Democratic National Committee is commandeering a taco truck to mock Trump's apparent fury at the slogan " Trump Always Chickens Out," or "TACO," Axios has learned. Why it matters: Democrats clearly think they have found a way to get under the president's skin. Trump was asked about the mantra — used by Wall Street traders to predict his response to tariff-induced market dips — at a press conference Wednesday, and he lashed out in response. "Don't ever say what you said. That's a nasty question," the president replied. Driving the news: The DNC will park a taco truck outside the Republican National Committee's headquarters on Capitol Hill with a graphic of Trump in a chicken suit and the "Trump Always Chickens Out" slogan. The truck will be there between noon and 2pm on Tuesday and will actually serve free tacos, a DNC spokesperson told Axios. What they're saying: "With his idiotic trade policy, he talks a big game, caves, and then leaves working families and small businesses to deal with the fallout," DNC chair Ken Martin said in a statement. "Trump always chickens out — we're just bringing the tacos to match." The other side: "LMFAO. A taco truck? Are they going to be giving out free vasectomies again too?" RNC spokesperson Zach Parkinson said in a statement, citing a past DNC pro-abortion initiative.
Yahoo
18 minutes ago
- Yahoo
Maps show U.S. air quality and Canada wildfire smoke forecast
Smoke spreading from wildfires in Canada was affecting air quality in multiple states on Tuesday. Parts of Minnesota, Iowa and Wisconsin were most at risk for unhealthy air, according to a federal measurement system called the Air Quality Index. The index has six ratings: good, moderate, unhealthy for sensitives groups, unhealthy, very unhealthy and hazardous. Sensitive groups include those who have a heart or lung disease, as well as older adults, children and pregnant women. The map below shows the current air quality across the U.S. var pymChild = new Other states, including Illinois, Michigan, Ohio, Pennsylvania and West Virginia, may see smoke from the fires, although the thickness will vary. In the Philadelphia region, for example, while smoke is expected to be visible, no major impacts on air quality are expected, CBS Philadelphia reported. Here's a look at where the smoke is expected to move on Tuesday and Wednesday. Around 200 active fires are burning in Canada, according to the Canadian Interagency Forest Fire Centre. More than 25,000 residents across three provinces had been evacuated due to the blazes as of Sunday, The Associated Press reported. January 6 defendant refuses Trump's pardon Everything we know about the Boulder attack on Israeli hostage march Exclusive discounts from CBS Mornings Deals
Yahoo
18 minutes ago
- Yahoo
Newark mayor sues New Jersey's top federal prosecutor after arrest at immigration detention site
NEWARK, N.J. (AP) — Newark Mayor Ras Baraka sued New Jersey's top federal prosecutor on Tuesday over his arrest on a trespassing charge at a federal immigration detention facility, saying the Trump-appointed attorney had pursued the case out of political spite. Baraka, who leads New Jersey's biggest city, is a candidate in a crowded primary field for the Democratic nomination for governor next Tuesday. The lawsuit against interim U.S. Attorney for New Jersey Alina Habba coincided with the day early in-person voting began. The lawsuit seeks damages for 'false arrest and malicious prosecution,' and also accuses Habba of defamation for comments she made about his case, which was later dropped. Citing a post on X in which Habba said Baraka 'committed trespass,' the lawsuit says Habba issued a 'defamatory statement' and authorized his 'false arrest' despite 'clear evidence that Mayor Baraka had not committed the petty offense of 'defiant trespass.'' The suit also names Ricky Patel, the Homeland Security Investigations agent in charge in Newark. 'This is not about revenge,' Baraka said during a news conference. 'Ultimately, it's about them taking accountability for what they did.' Emails seeking comment were left Tuesday with Habba's office and the Homeland Security Department, where Patel works. The episode outside the Delaney Hall federal immigration detention center has had dramatic fallout. It began on May 9 when Baraka tried to join three Democratic members of Congress — Rob Menendez, LaMonica McIver and Bonnie Watson Coleman — who went to the facility for an oversight tour, something authorized under federal law. Baraka, an outspoken critic of Trump's immigration crackdown and the detention center, was denied entry. Video from the event showed him walking from the facility side of the fence to the street side, where other people had been protesting, and then uniformed officials came to arrest him. As they did, people could be heard in the video saying to protect the mayor. The video shows a crowd forming and pushing as officials led off a handcuffed Baraka. He was initially charged with trespass, but Habba dropped that charge last month and charged McIver with two counts of assaulting officers stemming from her role in the skirmish at the facility's gate. U.S. Magistrate Judge Andre Espinosa rebuked Habba's office after moving to dismiss the charges. 'The hasty arrest of Newark Mayor Ras Baraka, followed swiftly by the dismissal of these trespassing charges a mere 13 days later, suggests a worrisome misstep by your Office,' he wrote. McIver decried the charges and signaled she plans to fight them. A preliminary hearing is scheduled later this month. Delaney Hall, a 1,000-bed facility, opened earlier this year as a federal immigration detention facility. Florida-based Geo Group Inc., which owns and operates the property, was awarded a 15-year contract valued at $1 billion in February. The announcement was part of the president's plans to sharply increase detention beds nationwide from a budget of about 41,000 beds this year. Baraka sued Geo soon after that deal was announced. Then, on May 23, the Trump Justice Department filed a suit against Newark and three other New Jersey cities over their so-called sanctuary policies. There is no legal definition for sanctuary city policies, but they generally limit cooperation by local law enforcement with federal immigration officers. New Jersey's attorney general has a statewide directive in place prohibiting local police from collaborating in federal civil immigration matters. The policies are aimed at barring cooperation on civil enforcement matters, not at blocking cooperation on criminal matters. They specifically carve out exceptions for when Immigration and Customs Enforcement supplies police with a judicial criminal warrant. The Justice Department said, though, the cities won't notify ICE when they've made criminal arrests, according to the suit. It's unclear whether Baraka's role in these fights with the Trump administration is having an effect on his campaign for governor. He's one of six candidates seeking the Democratic nomination in the June 10 election to succeed term-limited Democratic Gov. Phil Murphy. In a video ad in the election's final weeks, Baraka has embraced a theme his rivals are also pushing: affordability. He says he'll cut taxes. While some of the images show him standing in front of what appears to be Delaney Hall, he doesn't mention immigration or the arrest specifically, saying: 'I'll keep Trump out of your homes and out of your lives.' Trump has endorsed Jack Ciattarelli, one of several Republicans running in the gubernatorial primary. Ciattarelli has said if he's elected, his first executive order would be to end any sanctuary policies for immigrants in the country illegally. ___ Associated Press writer Alanna Durkin Richer in Washington contributed to this report.
